Immunotherapy Targeting of Cytomegalovirus Antigens in Glioblastoma
Clinical trial NCT06132438 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06132438
- Sponsor
- Charlotte Lemech
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-01
- Primary completion
- 2024-09-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.